

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | eosinophil chemotaxis (GO:0048245) | 9.42762169 |
| 2 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 9.01424168 |
| 3 | regulation of sister chromatid cohesion (GO:0007063) | 8.76742114 |
| 4 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 8.76719329 |
| 5 | eosinophil migration (GO:0072677) | 8.53979833 |
| 6 | regulation of mononuclear cell migration (GO:0071675) | 8.23647210 |
| 7 | L-fucose catabolic process (GO:0042355) | 7.59524251 |
| 8 | fucose catabolic process (GO:0019317) | 7.59524251 |
| 9 | L-fucose metabolic process (GO:0042354) | 7.59524251 |
| 10 | positive regulation of chromosome segregation (GO:0051984) | 7.56439568 |
| 11 | branch elongation of an epithelium (GO:0060602) | 7.43543489 |
| 12 | negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037) | 7.13062016 |
| 13 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 7.04694214 |
| 14 | peptidyl-lysine dimethylation (GO:0018027) | 7.00836370 |
| 15 | vesicle fusion (GO:0006906) | 6.77529148 |
| 16 | coenzyme A biosynthetic process (GO:0015937) | 6.54956282 |
| 17 | organ growth (GO:0035265) | 6.46072995 |
| 18 | macrophage chemotaxis (GO:0048246) | 6.34081491 |
| 19 | autophagic vacuole fusion (GO:0000046) | 6.07216442 |
| 20 | acrosome assembly (GO:0001675) | 5.64378946 |
| 21 | ribosomal small subunit assembly (GO:0000028) | 5.63779379 |
| 22 | axis elongation (GO:0003401) | 5.62061404 |
| 23 | establishment of mitotic spindle orientation (GO:0000132) | 5.39360287 |
| 24 | positive regulation of calcium ion import (GO:0090280) | 5.34552148 |
| 25 | localization within membrane (GO:0051668) | 5.25531504 |
| 26 | double-strand break repair via nonhomologous end joining (GO:0006303) | 5.22977121 |
| 27 | non-recombinational repair (GO:0000726) | 5.22977121 |
| 28 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 5.20964601 |
| 29 | regulation of beta-amyloid formation (GO:1902003) | 5.20346389 |
| 30 | protein import into peroxisome matrix (GO:0016558) | 5.15188715 |
| 31 | negative regulation of GTP catabolic process (GO:0033125) | 5.11739891 |
| 32 | negative regulation of GTPase activity (GO:0034260) | 5.11739891 |
| 33 | oxidative demethylation (GO:0070989) | 5.08733112 |
| 34 | regulation of T cell receptor signaling pathway (GO:0050856) | 4.97197074 |
| 35 | organelle membrane fusion (GO:0090174) | 4.93248855 |
| 36 | histone H3-K9 methylation (GO:0051567) | 4.78248722 |
| 37 | establishment of mitotic spindle localization (GO:0040001) | 4.77429785 |
| 38 | monocyte chemotaxis (GO:0002548) | 4.73463355 |
| 39 | establishment of spindle orientation (GO:0051294) | 4.72591777 |
| 40 | protein targeting to lysosome (GO:0006622) | 4.72109265 |
| 41 | establishment of protein localization to vacuole (GO:0072666) | 4.72109265 |
| 42 | protein targeting to vacuole (GO:0006623) | 4.72109265 |
| 43 | negative regulation of circadian rhythm (GO:0042754) | 4.66894113 |
| 44 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 4.55472958 |
| 45 | regulation of stem cell maintenance (GO:2000036) | 4.49805433 |
| 46 | DNA integration (GO:0015074) | 4.31471428 |
| 47 | ribonucleoside bisphosphate biosynthetic process (GO:0034030) | 4.26507361 |
| 48 | nucleoside bisphosphate biosynthetic process (GO:0033866) | 4.26507361 |
| 49 | purine nucleoside bisphosphate biosynthetic process (GO:0034033) | 4.26507361 |
| 50 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 4.22448611 |
| 51 | seminiferous tubule development (GO:0072520) | 4.16251855 |
| 52 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.14726373 |
| 53 | fucosylation (GO:0036065) | 4.09751909 |
| 54 | positive chemotaxis (GO:0050918) | 4.07573710 |
| 55 | organelle fusion (GO:0048284) | 4.02606646 |
| 56 | peptidyl-lysine trimethylation (GO:0018023) | 3.98752977 |
| 57 | pantothenate metabolic process (GO:0015939) | 3.96342703 |
| 58 | fucose metabolic process (GO:0006004) | 3.94735660 |
| 59 | regulation of fibroblast growth factor receptor signaling pathway (GO:0040036) | 3.93686041 |
| 60 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.92998913 |
| 61 | histone H3-K9 modification (GO:0061647) | 3.90194087 |
| 62 | coenzyme A metabolic process (GO:0015936) | 3.85027217 |
| 63 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 3.76764484 |
| 64 | negative regulation of dendrite development (GO:2000171) | 3.73683014 |
| 65 | protein sumoylation (GO:0016925) | 3.54210224 |
| 66 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.53757954 |
| 67 | membrane budding (GO:0006900) | 3.49384305 |
| 68 | DNA demethylation (GO:0080111) | 3.49012437 |
| 69 | negative regulation of purine nucleotide catabolic process (GO:0033122) | 3.47486889 |
| 70 | establishment of spindle localization (GO:0051293) | 3.46052360 |
| 71 | telomere maintenance via recombination (GO:0000722) | 3.43878734 |
| 72 | single-organism membrane fusion (GO:0044801) | 3.42012759 |
| 73 | protein localization to vacuole (GO:0072665) | 3.41614279 |
| 74 | protein localization to lysosome (GO:0061462) | 3.41614279 |
| 75 | regulation of peptidyl-threonine phosphorylation (GO:0010799) | 3.38897189 |
| 76 | labyrinthine layer development (GO:0060711) | 3.28538359 |
| 77 | imidazole-containing compound metabolic process (GO:0052803) | 3.26021040 |
| 78 | negative regulation of nucleotide catabolic process (GO:0030812) | 3.24561831 |
| 79 | negative regulation of macroautophagy (GO:0016242) | 3.23805521 |
| 80 | regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2 | 3.23232262 |
| 81 | regulation of calcium ion import (GO:0090279) | 3.21238155 |
| 82 | protein localization to peroxisome (GO:0072662) | 3.20455292 |
| 83 | protein targeting to peroxisome (GO:0006625) | 3.20455292 |
| 84 | establishment of protein localization to peroxisome (GO:0072663) | 3.20455292 |
| 85 | sodium-independent organic anion transport (GO:0043252) | 3.14710628 |
| 86 | negative regulation of nucleoside metabolic process (GO:0045978) | 3.13792145 |
| 87 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.08531868 |
| 88 | regulation of autophagic vacuole assembly (GO:2000785) | 3.06752688 |
| 89 | regulation of cellular amide metabolic process (GO:0034248) | 3.02877053 |
| 90 | regulation of T cell apoptotic process (GO:0070232) | 3.01673489 |
| 91 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.00762614 |
| 92 | COPII vesicle coating (GO:0048208) | 2.94512132 |
| 93 | negative regulation of Ras protein signal transduction (GO:0046580) | 2.93520049 |
| 94 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.91670166 |
| 95 | prenylation (GO:0097354) | 12.1906277 |
| 96 | protein prenylation (GO:0018342) | 12.1906277 |
| 97 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 11.9382836 |
| 98 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 11.9382836 |
| 99 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 11.9382836 |
| 100 | negative regulation of Ras GTPase activity (GO:0034261) | 11.2357530 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GATA1_22025678_ChIP-Seq_K562_Human | 9.02412849 |
| 2 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 6.15774863 |
| 3 | VDR_22108803_ChIP-Seq_LS180_Human | 5.56235304 |
| 4 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 3.79897945 |
| 5 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 3.63756340 |
| 6 | AR_21572438_ChIP-Seq_LNCaP_Human | 3.49819627 |
| 7 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.35626733 |
| 8 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.80869983 |
| 9 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.57449893 |
| 10 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.52819290 |
| 11 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.16700374 |
| 12 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.13202126 |
| 13 | RXR_22108803_ChIP-Seq_LS180_Human | 2.12695510 |
| 14 | FUS_26573619_Chip-Seq_HEK293_Human | 2.09709108 |
| 15 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 2.05133831 |
| 16 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.05133831 |
| 17 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.02486007 |
| 18 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.96127772 |
| 19 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.95994024 |
| 20 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.88141610 |
| 21 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.83756490 |
| 22 | TP53_16413492_ChIP-PET_HCT116_Human | 1.78752139 |
| 23 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.66575492 |
| 24 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.65669296 |
| 25 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.65372137 |
| 26 | P300_19829295_ChIP-Seq_ESCs_Human | 1.63450981 |
| 27 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.62884134 |
| 28 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.60887883 |
| 29 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.53496450 |
| 30 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.49175110 |
| 31 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.47521404 |
| 32 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.39618674 |
| 33 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.39206131 |
| 34 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.39175227 |
| 35 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.36496711 |
| 36 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.30808832 |
| 37 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.29516731 |
| 38 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.29037807 |
| 39 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.26140474 |
| 40 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.26092810 |
| 41 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.25323119 |
| 42 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.25323119 |
| 43 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.24077499 |
| 44 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.23224881 |
| 45 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.23170068 |
| 46 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.22210042 |
| 47 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.19002172 |
| 48 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.17321199 |
| 49 | GATA3_26560356_Chip-Seq_TH1_Human | 1.16873368 |
| 50 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.15067654 |
| 51 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.14943709 |
| 52 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.12220502 |
| 53 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.10751777 |
| 54 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.08736013 |
| 55 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.08207498 |
| 56 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.04798656 |
| 57 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 1.03781255 |
| 58 | STAT3_23295773_ChIP-Seq_U87_Human | 1.03334545 |
| 59 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.01474546 |
| 60 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.98476821 |
| 61 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.96636028 |
| 62 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.96636028 |
| 63 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.96636028 |
| 64 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.96485624 |
| 65 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.96294185 |
| 66 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.96118469 |
| 67 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.95130803 |
| 68 | KDM2B_26808549_Chip-Seq_REH_Human | 0.94684040 |
| 69 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.94312702 |
| 70 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.93637823 |
| 71 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.93247432 |
| 72 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.93163160 |
| 73 | EWS_26573619_Chip-Seq_HEK293_Human | 0.92771183 |
| 74 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.92515601 |
| 75 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.91321901 |
| 76 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.91137638 |
| 77 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.91137638 |
| 78 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.90590105 |
| 79 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.90559364 |
| 80 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.89844058 |
| 81 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89782008 |
| 82 | AR_25329375_ChIP-Seq_VCAP_Human | 0.88700820 |
| 83 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.88183741 |
| 84 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88159667 |
| 85 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.87391792 |
| 86 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.87302824 |
| 87 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.87114642 |
| 88 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.85962737 |
| 89 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.85648016 |
| 90 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.85380913 |
| 91 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.83986859 |
| 92 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.83789632 |
| 93 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.83353247 |
| 94 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.81839760 |
| 95 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.80829004 |
| 96 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.80638417 |
| 97 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.79713664 |
| 98 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.79500285 |
| 99 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.79152602 |
| 100 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.78606991 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 8.53973486 |
| 2 | MP0006082_CNS_inflammation | 4.44410312 |
| 3 | MP0003136_yellow_coat_color | 3.55068022 |
| 4 | MP0002751_abnormal_autonomic_nervous | 3.17833368 |
| 5 | MP0001664_abnormal_digestion | 3.03153320 |
| 6 | MP0000467_abnormal_esophagus_morphology | 3.00284527 |
| 7 | MP0003115_abnormal_respiratory_system | 2.70325655 |
| 8 | MP0001663_abnormal_digestive_system | 2.68318487 |
| 9 | MP0001919_abnormal_reproductive_system | 2.42948763 |
| 10 | MP0000383_abnormal_hair_follicle | 2.26618240 |
| 11 | MP0005381_digestive/alimentary_phenotyp | 2.04212890 |
| 12 | MP0000566_synostosis | 11.5621999 |
| 13 | MP0003937_abnormal_limbs/digits/tail_de | 1.80830786 |
| 14 | MP0005389_reproductive_system_phenotype | 1.78445767 |
| 15 | MP0002876_abnormal_thyroid_physiology | 1.77059117 |
| 16 | MP0001915_intracranial_hemorrhage | 1.75095243 |
| 17 | MP0010678_abnormal_skin_adnexa | 1.72205548 |
| 18 | MP0001286_abnormal_eye_development | 1.71435464 |
| 19 | MP0005171_absent_coat_pigmentation | 1.66644104 |
| 20 | MP0001293_anophthalmia | 1.65905784 |
| 21 | MP0000534_abnormal_ureter_morphology | 1.55856209 |
| 22 | MP0000428_abnormal_craniofacial_morphol | 1.41665347 |
| 23 | MP0002822_catalepsy | 1.41117551 |
| 24 | MP0001984_abnormal_olfaction | 1.39355001 |
| 25 | MP0001545_abnormal_hematopoietic_system | 1.27458759 |
| 26 | MP0005397_hematopoietic_system_phenotyp | 1.27458759 |
| 27 | MP0005076_abnormal_cell_differentiation | 1.27101713 |
| 28 | MP0000569_abnormal_digit_pigmentation | 1.15421187 |
| 29 | MP0005166_decreased_susceptibility_to | 1.13161741 |
| 30 | MP0003453_abnormal_keratinocyte_physiol | 1.05864480 |
| 31 | MP0002109_abnormal_limb_morphology | 1.05148890 |
| 32 | MP0005253_abnormal_eye_physiology | 1.01469347 |
| 33 | MP0005187_abnormal_penis_morphology | 1.00414408 |
| 34 | MP0003763_abnormal_thymus_physiology | 0.99945824 |
| 35 | MP0002102_abnormal_ear_morphology | 0.98306225 |
| 36 | MP0003935_abnormal_craniofacial_develop | 0.93826066 |
| 37 | MP0003942_abnormal_urinary_system | 0.93169896 |
| 38 | MP0005501_abnormal_skin_physiology | 0.89116263 |
| 39 | MP0008058_abnormal_DNA_repair | 0.87187586 |
| 40 | MP0005645_abnormal_hypothalamus_physiol | 0.83520727 |
| 41 | MP0000490_abnormal_crypts_of | 0.83397461 |
| 42 | MP0001764_abnormal_homeostasis | 0.83180081 |
| 43 | MP0000026_abnormal_inner_ear | 0.82631074 |
| 44 | MP0005197_abnormal_uvea_morphology | 0.81798665 |
| 45 | MP0005391_vision/eye_phenotype | 0.80084194 |
| 46 | MP0002019_abnormal_tumor_incidence | 0.78304142 |
| 47 | MP0000358_abnormal_cell_content/ | 0.77919347 |
| 48 | MP0002184_abnormal_innervation | 0.77530923 |
| 49 | MP0002697_abnormal_eye_size | 0.76510254 |
| 50 | MP0001963_abnormal_hearing_physiology | 0.76304240 |
| 51 | MP0003880_abnormal_central_pattern | 0.75684051 |
| 52 | MP0000432_abnormal_head_morphology | 0.72723509 |
| 53 | MP0000470_abnormal_stomach_morphology | 0.71668779 |
| 54 | MP0000778_abnormal_nervous_system | 0.71043104 |
| 55 | MP0002115_abnormal_skeleton_extremities | 0.70595935 |
| 56 | MP0000516_abnormal_urinary_system | 0.69549606 |
| 57 | MP0005367_renal/urinary_system_phenotyp | 0.69549606 |
| 58 | MP0002752_abnormal_somatic_nervous | 0.65927961 |
| 59 | MP0006276_abnormal_autonomic_nervous | 0.65138383 |
| 60 | MP0006072_abnormal_retinal_apoptosis | 0.65113959 |
| 61 | MP0002160_abnormal_reproductive_system | 0.65022501 |
| 62 | MP0005195_abnormal_posterior_eye | 0.64868668 |
| 63 | MP0000858_altered_metastatic_potential | 0.64180340 |
| 64 | MP0002210_abnormal_sex_determination | 0.63524199 |
| 65 | MP0003646_muscle_fatigue | 0.61819554 |
| 66 | MP0002234_abnormal_pharynx_morphology | 0.60168504 |
| 67 | MP0004270_analgesia | 0.57956655 |
| 68 | MP0001175_abnormal_lung_morphology | 0.56870106 |
| 69 | MP0001529_abnormal_vocalization | 0.55679056 |
| 70 | MP0000477_abnormal_intestine_morphology | 0.51874332 |
| 71 | MP0002928_abnormal_bile_duct | 0.51663709 |
| 72 | MP0000955_abnormal_spinal_cord | 0.49721411 |
| 73 | MP0002092_abnormal_eye_morphology | 0.49583739 |
| 74 | MP0008995_early_reproductive_senescence | 0.48735682 |
| 75 | MP0003632_abnormal_nervous_system | 0.48108639 |
| 76 | MP0005508_abnormal_skeleton_morphology | 0.48053254 |
| 77 | MP0008057_abnormal_DNA_replication | 0.45838153 |
| 78 | MP0005551_abnormal_eye_electrophysiolog | 0.45426647 |
| 79 | MP0003077_abnormal_cell_cycle | 0.45042911 |
| 80 | MP0004197_abnormal_fetal_growth/weight/ | 0.43364946 |
| 81 | MP0002882_abnormal_neuron_morphology | 0.42573540 |
| 82 | MP0003315_abnormal_perineum_morphology | 0.41950238 |
| 83 | MP0002113_abnormal_skeleton_development | 0.41907571 |
| 84 | MP0009672_abnormal_birth_weight | 0.39775103 |
| 85 | MP0002081_perinatal_lethality | 0.39755797 |
| 86 | MP0002735_abnormal_chemical_nociception | 0.39602577 |
| 87 | MP0004484_altered_response_of | 0.39259543 |
| 88 | MP0003329_amyloid_beta_deposits | 0.38330540 |
| 89 | MP0009046_muscle_twitch | 0.38303132 |
| 90 | MP0008770_decreased_survivor_rate | 0.38137079 |
| 91 | MP0005248_abnormal_Harderian_gland | 0.38111372 |
| 92 | MP0002277_abnormal_respiratory_mucosa | 0.37354729 |
| 93 | MP0000372_irregular_coat_pigmentation | 0.36338821 |
| 94 | MP0006054_spinal_hemorrhage | 0.36294323 |
| 95 | MP0000377_abnormal_hair_follicle | 0.35594578 |
| 96 | MP0004811_abnormal_neuron_physiology | 0.34935198 |
| 97 | MP0005423_abnormal_somatic_nervous | 0.34890451 |
| 98 | MP0001661_extended_life_span | 0.34110001 |
| 99 | MP0009745_abnormal_behavioral_response | 0.34013984 |
| 100 | MP0001119_abnormal_female_reproductive | 0.33803875 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 9.92498379 |
| 2 | Long foot (HP:0001833) | 8.36487103 |
| 3 | Duplicated collecting system (HP:0000081) | 8.07907823 |
| 4 | Abnormality of the renal collecting system (HP:0004742) | 7.26012388 |
| 5 | Hypoplastic pelvis (HP:0008839) | 7.01179032 |
| 6 | Large for gestational age (HP:0001520) | 6.84663170 |
| 7 | Adactyly (HP:0009776) | 6.83113869 |
| 8 | Acute lymphatic leukemia (HP:0006721) | 6.14227871 |
| 9 | Dry hair (HP:0011359) | 5.24466680 |
| 10 | Abnormal auditory evoked potentials (HP:0006958) | 5.15431929 |
| 11 | Progressive muscle weakness (HP:0003323) | 4.98162844 |
| 12 | Pulmonary artery stenosis (HP:0004415) | 4.89576907 |
| 13 | Menstrual irregularities (HP:0000858) | 4.79688580 |
| 14 | Autoamputation (HP:0001218) | 4.78425412 |
| 15 | Hypoplastic nipples (HP:0002557) | 4.76705893 |
| 16 | Ureteral stenosis (HP:0000071) | 4.75293255 |
| 17 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.61274430 |
| 18 | Decreased lacrimation (HP:0000633) | 4.55677800 |
| 19 | Ureteral obstruction (HP:0006000) | 4.41018291 |
| 20 | Broad-based gait (HP:0002136) | 4.32261190 |
| 21 | Brushfield spots (HP:0001088) | 4.12037743 |
| 22 | Increased number of teeth (HP:0011069) | 4.09145719 |
| 23 | Ureteral duplication (HP:0000073) | 4.02387452 |
| 24 | Steatorrhea (HP:0002570) | 3.83417678 |
| 25 | Sudden death (HP:0001699) | 3.67684723 |
| 26 | Severe muscular hypotonia (HP:0006829) | 3.63267821 |
| 27 | Abnormal connection of the cardiac segments (HP:0011545) | 3.48686746 |
| 28 | Abnormal ventriculo-arterial connection (HP:0011563) | 3.48686746 |
| 29 | Transposition of the great arteries (HP:0001669) | 3.48686746 |
| 30 | Anhidrosis (HP:0000970) | 3.40698648 |
| 31 | Reduced subcutaneous adipose tissue (HP:0003758) | 3.33126356 |
| 32 | Hypoplastic iliac wings (HP:0002866) | 3.32398362 |
| 33 | Wide intermamillary distance (HP:0006610) | 3.19211088 |
| 34 | Palmoplantar hyperkeratosis (HP:0000972) | 3.18138382 |
| 35 | Clubbing of toes (HP:0100760) | 3.17958393 |
| 36 | Abnormality of vision evoked potentials (HP:0000649) | 3.11200505 |
| 37 | Palmar hyperkeratosis (HP:0010765) | 3.09720439 |
| 38 | Polymicrogyria (HP:0002126) | 3.05050143 |
| 39 | Broad nasal tip (HP:0000455) | 2.94922134 |
| 40 | Fat malabsorption (HP:0002630) | 2.94013954 |
| 41 | Decreased muscle mass (HP:0003199) | 2.93073320 |
| 42 | Large hands (HP:0001176) | 2.79435983 |
| 43 | Widely spaced teeth (HP:0000687) | 2.74730584 |
| 44 | Chorioretinal coloboma (HP:0000567) | 2.70282372 |
| 45 | Polyneuropathy (HP:0001271) | 2.53909320 |
| 46 | Steppage gait (HP:0003376) | 2.45475866 |
| 47 | Plantar hyperkeratosis (HP:0007556) | 2.41365392 |
| 48 | Flat face (HP:0012368) | 2.36804233 |
| 49 | Septo-optic dysplasia (HP:0100842) | 2.33365574 |
| 50 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 2.28635601 |
| 51 | Spastic tetraplegia (HP:0002510) | 2.26328339 |
| 52 | Thickened calvaria (HP:0002684) | 2.21115413 |
| 53 | Overfolded helix (HP:0000396) | 2.20507408 |
| 54 | Absent toe (HP:0010760) | 2.18775520 |
| 55 | Abnormality of the epiphyses of the hand (HP:0005924) | 2.15776291 |
| 56 | Myoglobinuria (HP:0002913) | 2.08491516 |
| 57 | Abnormality involving the epiphyses of the upper limbs (HP:0003839) | 2.02517775 |
| 58 | Epiphyseal stippling (HP:0010655) | 2.01961066 |
| 59 | Generalized amyotrophy (HP:0003700) | 2.01359033 |
| 60 | Aplasia/Hypoplasia of the nipples (HP:0006709) | 2.00443837 |
| 61 | Esophageal atresia (HP:0002032) | 1.95822022 |
| 62 | Postnatal growth retardation (HP:0008897) | 1.95704135 |
| 63 | Abnormally folded helix (HP:0008544) | 1.91835175 |
| 64 | Hypoplastic ilia (HP:0000946) | 1.88732888 |
| 65 | Female pseudohermaphroditism (HP:0010458) | 1.84946896 |
| 66 | External ear malformation (HP:0008572) | 1.82139469 |
| 67 | Progressive cerebellar ataxia (HP:0002073) | 1.81012100 |
| 68 | Short philtrum (HP:0000322) | 1.79331006 |
| 69 | Rhabdomyolysis (HP:0003201) | 1.77701703 |
| 70 | Abnormality of the line of Schwalbe (HP:0008048) | 1.77592001 |
| 71 | Thickened nuchal skin fold (HP:0000474) | 1.76379718 |
| 72 | Anxiety (HP:0000739) | 1.76352926 |
| 73 | Congenital onset (HP:0003577) | 1.74330793 |
| 74 | Gaze-evoked nystagmus (HP:0000640) | 1.74028675 |
| 75 | Scrotal hypoplasia (HP:0000046) | 1.71833128 |
| 76 | Freckling (HP:0001480) | 1.66939092 |
| 77 | Aplasia/Hypoplasia involving the pelvis (HP:0009103) | 1.66924338 |
| 78 | Hammertoe (HP:0001765) | 1.65479181 |
| 79 | Thyroiditis (HP:0100646) | 1.63973611 |
| 80 | Chronic hepatic failure (HP:0100626) | 1.61213606 |
| 81 | Posterior embryotoxon (HP:0000627) | 1.58625155 |
| 82 | Prenatal maternal abnormality (HP:0002686) | 1.57365275 |
| 83 | Abnormality of the wing of the ilium (HP:0011867) | 1.55335289 |
| 84 | Abnormal epiphyseal ossification (HP:0010656) | 1.51271321 |
| 85 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.51032809 |
| 86 | Primary adrenal insufficiency (HP:0008207) | 1.50818781 |
| 87 | Foot dorsiflexor weakness (HP:0009027) | 1.49483148 |
| 88 | Aqueductal stenosis (HP:0002410) | 1.48724671 |
| 89 | Hypoplasia of the corpus callosum (HP:0002079) | 1.47998101 |
| 90 | Generalized muscle weakness (HP:0003324) | 1.46637973 |
| 91 | Dolichocephaly (HP:0000268) | 1.43017187 |
| 92 | Optic nerve hypoplasia (HP:0000609) | 1.42159789 |
| 93 | Decreased testicular size (HP:0008734) | 1.41411985 |
| 94 | Stereotypic behavior (HP:0000733) | 1.40540640 |
| 95 | Brachycephaly (HP:0000248) | 1.39145343 |
| 96 | Dyschromatopsia (HP:0007641) | 1.38519669 |
| 97 | Basal ganglia calcification (HP:0002135) | 1.36124920 |
| 98 | Abnormality of the foot musculature (HP:0001436) | 1.35875809 |
| 99 | Gastrointestinal atresia (HP:0002589) | 1.33694258 |
| 100 | Oligodactyly (hands) (HP:0001180) | 1.33030268 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MKNK1 | 6.68734486 |
| 2 | TAOK1 | 5.16785655 |
| 3 | TAOK2 | 5.07518519 |
| 4 | MAP3K11 | 4.01573490 |
| 5 | MAP2K3 | 3.80127592 |
| 6 | MAP3K3 | 3.66859102 |
| 7 | JAK3 | 2.17363154 |
| 8 | MKNK2 | 11.3654860 |
| 9 | DYRK1A | 1.88868074 |
| 10 | ABL2 | 1.62066430 |
| 11 | FRK | 1.49019721 |
| 12 | MAP3K5 | 1.40897092 |
| 13 | CASK | 1.17392350 |
| 14 | SRPK1 | 1.11875941 |
| 15 | MAP3K1 | 0.96473286 |
| 16 | MAP4K2 | 0.85628752 |
| 17 | CHEK2 | 0.78838482 |
| 18 | MAPK15 | 0.64978979 |
| 19 | WNK3 | 0.57767377 |
| 20 | FGFR2 | 0.56072656 |
| 21 | INSRR | 0.51714057 |
| 22 | MAP3K4 | 0.48868305 |
| 23 | MAP3K8 | 0.47117674 |
| 24 | PNCK | 0.46758375 |
| 25 | PRKCQ | 0.45744237 |
| 26 | PLK4 | 0.45376158 |
| 27 | RPS6KA4 | 0.39806533 |
| 28 | MAP2K7 | 0.38980872 |
| 29 | OBSCN | 0.38670409 |
| 30 | TGFBR2 | 0.28282023 |
| 31 | TSSK6 | 0.28000755 |
| 32 | GRK7 | 0.26603502 |
| 33 | PINK1 | 0.26568517 |
| 34 | NTRK2 | 0.25644165 |
| 35 | BCR | 0.24826771 |
| 36 | MAPK13 | 0.22813177 |
| 37 | CSNK1A1 | 0.21145131 |
| 38 | ABL1 | 0.18036727 |
| 39 | CDK3 | 0.18032645 |
| 40 | MAP2K4 | 0.17890354 |
| 41 | MARK1 | 0.17353596 |
| 42 | STK38L | 0.17230505 |
| 43 | BLK | 0.16357960 |
| 44 | TIE1 | 0.16031036 |
| 45 | WEE1 | 0.14830108 |
| 46 | IGF1R | 0.14415873 |
| 47 | PLK2 | 0.13662804 |
| 48 | TNIK | 0.12840788 |
| 49 | STK39 | 0.12506435 |
| 50 | ZAK | 0.12445894 |
| 51 | PAK3 | 0.11858293 |
| 52 | AKT3 | 0.11418495 |
| 53 | CCNB1 | 0.09537059 |
| 54 | VRK1 | 0.09418145 |
| 55 | ERBB3 | 0.09263126 |
| 56 | ADRBK2 | 0.08950174 |
| 57 | CAMKK2 | 0.08586588 |
| 58 | OXSR1 | 0.07841872 |
| 59 | ACVR1B | 0.07397784 |
| 60 | IKBKE | 0.06452456 |
| 61 | FGFR3 | 0.06401890 |
| 62 | PIK3CG | 0.06312992 |
| 63 | ERBB4 | 0.05752370 |
| 64 | TRIM28 | 0.05486989 |
| 65 | BMPR1B | 0.04635212 |
| 66 | GRK5 | 0.03791150 |
| 67 | TNK2 | 0.03758460 |
| 68 | PRKCB | 0.03284368 |
| 69 | BCKDK | 0.03274691 |
| 70 | PKN1 | 0.02877129 |
| 71 | GRK1 | 0.02625321 |
| 72 | PLK3 | 0.02469779 |
| 73 | RPS6KA5 | 0.02341503 |
| 74 | SGK2 | 0.02091283 |
| 75 | PRKCE | 0.01577530 |
| 76 | ERBB2 | 0.01335612 |
| 77 | CSNK2A2 | 0.01034699 |
| 78 | DDR2 | 0.01016727 |
| 79 | PAK6 | 0.00889648 |
| 80 | ADRBK1 | 0.00208659 |
| 81 | TXK | 0.00183691 |
| 82 | EGFR | -0.0446850 |
| 83 | LYN | -0.0437641 |
| 84 | CAMK1G | -0.0413359 |
| 85 | AURKA | -0.0344387 |
| 86 | PRKCD | -0.0326513 |
| 87 | MUSK | -0.0317846 |
| 88 | NTRK3 | -0.0289198 |
| 89 | CSNK1E | -0.0261130 |
| 90 | PRKCA | -0.0259629 |
| 91 | CAMK1D | -0.0210736 |
| 92 | KDR | -0.0208326 |
| 93 | CDC7 | -0.0189849 |
| 94 | PRKACA | -0.0173470 |
| 95 | TEC | -0.0169675 |
| 96 | CSNK2A1 | -0.0120695 |
| 97 | TTK | -0.0109839 |
| 98 | KSR1 | -0.0084511 |
| 99 | PRKCG | -0.0063191 |
| 100 | CAMK2A | -0.0014826 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 7.07899133 |
| 2 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 6.87175708 |
| 3 | Lysine degradation_Homo sapiens_hsa00310 | 3.06213897 |
| 4 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 3.04537754 |
| 5 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.98264404 |
| 6 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.59169134 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.45867644 |
| 8 | RNA polymerase_Homo sapiens_hsa03020 | 2.13396666 |
| 9 | Nicotine addiction_Homo sapiens_hsa05033 | 2.08138349 |
| 10 | * Taste transduction_Homo sapiens_hsa04742 | 2.07334755 |
| 11 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.03727387 |
| 12 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.00934888 |
| 13 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.86044565 |
| 14 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.60504000 |
| 15 | Amoebiasis_Homo sapiens_hsa05146 | 1.54128558 |
| 16 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.53416324 |
| 17 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.33406452 |
| 18 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.26077845 |
| 19 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.21245776 |
| 20 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.16965878 |
| 21 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.14244337 |
| 22 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.12655622 |
| 23 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.11541349 |
| 24 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.07394600 |
| 25 | GABAergic synapse_Homo sapiens_hsa04727 | 1.06244095 |
| 26 | Olfactory transduction_Homo sapiens_hsa04740 | 1.04530195 |
| 27 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.04311771 |
| 28 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.01362593 |
| 29 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.01119362 |
| 30 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.01097622 |
| 31 | Morphine addiction_Homo sapiens_hsa05032 | 0.94122385 |
| 32 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.90815008 |
| 33 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.87844493 |
| 34 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.86365112 |
| 35 | Alcoholism_Homo sapiens_hsa05034 | 0.82443466 |
| 36 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.78659573 |
| 37 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.75261932 |
| 38 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.73459857 |
| 39 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.72675182 |
| 40 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.71096259 |
| 41 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.70850532 |
| 42 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.69751447 |
| 43 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.69596213 |
| 44 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.69549061 |
| 45 | Proteasome_Homo sapiens_hsa03050 | 0.66280878 |
| 46 | Viral myocarditis_Homo sapiens_hsa05416 | 0.65856197 |
| 47 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.64752412 |
| 48 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.60312549 |
| 49 | ABC transporters_Homo sapiens_hsa02010 | 0.60161014 |
| 50 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.58649350 |
| 51 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.53435494 |
| 52 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.53309456 |
| 53 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.52626597 |
| 54 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.52340534 |
| 55 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.51914888 |
| 56 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.51828125 |
| 57 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.51301896 |
| 58 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.50689402 |
| 59 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.49901012 |
| 60 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.49863919 |
| 61 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.49666388 |
| 62 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.48815180 |
| 63 | Renin secretion_Homo sapiens_hsa04924 | 0.45536260 |
| 64 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.44742108 |
| 65 | Peroxisome_Homo sapiens_hsa04146 | 0.44573400 |
| 66 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.44388406 |
| 67 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.43897343 |
| 68 | Circadian entrainment_Homo sapiens_hsa04713 | 0.42919221 |
| 69 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.42367875 |
| 70 | Gap junction_Homo sapiens_hsa04540 | 0.40668819 |
| 71 | Cocaine addiction_Homo sapiens_hsa05030 | 0.39672405 |
| 72 | Melanogenesis_Homo sapiens_hsa04916 | 0.39668505 |
| 73 | Melanoma_Homo sapiens_hsa05218 | 0.39628011 |
| 74 | Phototransduction_Homo sapiens_hsa04744 | 0.37471919 |
| 75 | Salmonella infection_Homo sapiens_hsa05132 | 0.37119662 |
| 76 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.34318556 |
| 77 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.33595454 |
| 78 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.33224236 |
| 79 | Retinol metabolism_Homo sapiens_hsa00830 | 0.32620046 |
| 80 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.31758342 |
| 81 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.31700882 |
| 82 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.30496574 |
| 83 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.29715758 |
| 84 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.25461211 |
| 85 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.25071535 |
| 86 | RNA transport_Homo sapiens_hsa03013 | 0.22584428 |
| 87 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.21821650 |
| 88 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.21714758 |
| 89 | Axon guidance_Homo sapiens_hsa04360 | 0.20562336 |
| 90 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.20400069 |
| 91 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.20194888 |
| 92 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.19920759 |
| 93 | Tuberculosis_Homo sapiens_hsa05152 | 0.19597395 |
| 94 | Purine metabolism_Homo sapiens_hsa00230 | 0.19223547 |
| 95 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.18285634 |
| 96 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.15914100 |
| 97 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.15363216 |
| 98 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.15350320 |
| 99 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.14812746 |
| 100 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.13923149 |

